This guidance represents the view of the Institute, which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. The guidance does not, however, override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
NICE technology appraisal guidance 123 Varenicline for smoking cessation

Ordering information
You can download the following documents from www.nice.org.uk/TA123
The full guidance (this document). A quick reference guide for healthcare professionals. Information for people who want to quit smoking and their carers ('Understanding NICE guidance'). Details of all the evidence that was looked at and other background information.
For printed copies of the quick reference guide or 'Understanding NICE guidance', phone the NHS Response Line on 0870 1555 455 and quote: N1284 (quick reference guide) N1285 ('Understanding NICE guidance'). NRT and bupropion in all sensitivity analysis.
Guidance
3.6
The ERG noted that the inclusion/exclusion criteria of the metaanalysis in the manufacturer's submission differed from existing analyses by the Cochrane collaboration and considered that they could overestimate the efficacy of varenicline. The ERG also conducted its own meta-analysis and indirect comparison which suggested that the odds ratio for varenicline in comparison with NRT was lower than in the manufacturer's model: OR 1.54 (95% CI 1.10 to 2.16).
3.7
The ERG noted that the assumptions included in the model could make external validity questionable. For example, it considered that the assumption of a single quit attempt was a limitation that did not allow consideration of the impact of subsequent quit attempts on costs, morbidity or mortality. In addition, the extrapolation of data Local costing template incorporating a costing report to estimate the savings and costs associated with implementation.
Implementation
Audit criteria to monitor local practice.
6
Recommendation for further research
The Committee recommends that research is conducted into the long-term effectiveness of smoking cessation interventions with particular reference to relapse rates after completion of treatment. 
C. NICE project team
Each technology appraisal is assigned to a team consisting of one or more health technology analysts (who act as technical leads for the appraisal), a technical adviser and a project manager.
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